Celerion is committed to swift, exceptional clinical research through translational medicine. Every day, we use our experience, agility, and innovative research strategies to help get drugs to market faster.
As a Research Screening Specialist, you will be responsible for the preparation and maintenance of all stages of participant activities including screening, training, and evaluations. Duties include entering and updating study information into database systems, collecting and organizing panelist’s paperwork and documentation, and developing positive participant communications and relationships.
In this entry level role you will work in an office / clinic environment with a team of 10 colleagues all committed to the same mission: assisting in the development of drugs that will touch the lives of family, friends, and people in need around the world.
We prefer an Associate's degree in social or biological sciences or a hospitality related field, excellent oral and written communication skills, excellent organizational skills, and the ability to multi-task effectively.
This full time position will work Monday-Friday 5:30am-2:00pm.
If you are seeking a future career in medicine or just want to know more about clinical research, this role is a springboard to professional growth and opportunities for advancement.
We offer:
A dynamic, groundbreaking and team oriented work environment and a comprehensive benefit package.
Celerion Values: Integrity Trust Teamwork Respect
Celerion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, genetic information, marital status, qualified protected veteran status, or disability.
Celerion’s focus is on the implementation of innovative strategies to generate key data very early to enable go/no-go decisions in drug development. With a large clinical capacity of more than 600 beds , efficient bioanalytical laboratories and ex...
9 jobsSubscribe to Rise newsletter